CytoDyn Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.21 |
Market Cap |
$167.64 M |
Shares Outstanding |
364.43 M |
Public Float |
254.81 M |
Address |
1111 Main Street Vancouver Washington 98660 United States |
Employees | - |
Website | http://www.cytodyn.com |
Updated | 07/08/2019 |
CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus infection. Its product pipeline includes PRO 140, CytoFeline, and Cytolin. The company was founded by Allen D. |